Sufficient and uninterrupted supply

What we measure: Number of Gavi vaccine markets where supply of appropriate vaccines is both sufficient and uninterrupted to meet demand.

KPI 4.1

Cost of fully vaccinating a child with pentavalent, pneumococcal and rotavirus vaccines

What we measure: The weighted average vaccine price of fully immunising a child with pentavalent, pneumococcal and rotavirus vaccines.

KPI 4.2

Innovation

What we measure: Number of vaccines and other related products with improved characteristics procured compared with the baseline year.

KPI 4.3

Healthy market dynamics

What we measure: Number of Gavi vaccine markets classified as benefiting from high or moderate health. Each vaccine market is rated as having high, moderate or low market health, or as having no healthy market dynamics.

KPI 4.4

Some figures from previous years have been updated due to revisions of historical data.

Our 2016-2020 strategy

November 11, 2019

The market shaping goal (Phase 4)

Shape markets for vaccines and other immunisation products

Subscribe to our newsletter